Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ranexa 375mg modified-release tablets
0206030Z0BBAAAA
|
Ranexa | Ranolazine | Cardiovascular System | 1,758 |
|
Ranexa 500mg modified-release tablets
0206030Z0BBABAB
|
Ranexa | Ranolazine | Cardiovascular System | 1,034 |
|
Ranexa 750mg modified-release tablets
0206030Z0BBACAC
|
Ranexa | Ranolazine | Cardiovascular System | 451 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.